CIK 0001841387 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Candel Therapeutics, Inc.
Sign in to watch- Ticker
- CADL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522214851
- Phone
- 617-916-5445
- Business address
- 117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,244,783
- in 2 filings, $3.2M under 10b5-1 plans
Net −$3,244,783. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-11 | Tak Paul Peter Chief Executive Officer | Sale 10b5-1 | −59,379 | $10.46 | $621K | 113,321 |
| 2026-09-10 | Tak Paul Peter Chief Executive Officer | Sale 10b5-1 | −220,866 | $11.50 | $2.5M | 172,700 |
| 2026-08-17 | Tyagarajan Seshu Chief Technology Officer | Sale 10b5-1 | −7,000 | $12.00 | $84K | 76,865 |
| 2026-06-29 | Tyagarajan Seshu Chief Technology Officer | Sale 10b5-1 | −7,000 | $10.02 | $70K | 83,865 |
| 2026-06-29 | Barone Francesca Chief Scientific Officer | Sale 10b5-1 | −23,447 | $10.06 | $236K | 77,362 |
| 2025-07-28 | Nichols William Garrett Chief Medical Officer | Sale 10b5-1 | −937 | $6.98 | $7K | 52,493 |
| 2025-06-30 | Nichols William Garrett Chief Medical Officer | Sale 10b5-1 | −781 | $5.04 | $4K | 52,493 |
| 2025-03-19 | Tak Paul Peter Chief Executive Officer | Sale 10b5-1 | −400 | $9.00 | $4K | 225,740 |
| 2025-03-18 | Nichols William Garrett Chief Medical Officer | Sale 10b5-1 | −45,316 | $8.76 | $397K | 52,493 |
| 2025-03-18 | Barone Francesca Chief Scientific Officer | Sale 10b5-1 | −32,146 | $8.76 | $282K | 96,527 |
| 2025-03-18 | Tak Paul Peter Chief Executive Officer | Sale 10b5-1 | −25,772 | $8.77 | $226K | 226,140 |
| 2025-03-17 | Tyagarajan Seshu Chief Technology Officer | Sale 10b5-1 | −31,278 | $8.82 | $276K | 85,512 |
| 2025-03-17 | Tyagarajan Seshu Chief Technology Officer | Sale 10b5-1 | −31,278 | $8.82 | $276K | 85,512 |
| 2025-03-17 | Schoch Charles See Remarks | Sale 10b5-1 | −5,000 | $8.83 | $44K | 38,038 |
| 2025-01-15 | Tyagarajan Seshu Chief Technology Officer | Sale | −14,322 | $7.23 | $103K | 96,790 |
| 2025-01-15 | Barone Francesca Chief Scientific Officer | Sale | −13,534 | $7.23 | $98K | 110,673 |
| 2025-01-15 | Schoch Charles See Remarks | Sale | −9,511 | $7.23 | $69K | 43,038 |
| 2025-01-15 | Tak Paul Peter Chief Executive Officer | Sale | −21,704 | $7.23 | $157K | 251,912 |
| 2025-01-15 | Nichols William Garrett Chief Medical Officer | Sale | −10,428 | $7.23 | $75K | 79,320 |
| 2025-01-08 | Barone Francesca Chief Scientific Officer | Sale | −13,673 | $8.22 | $112K | 124,207 |
Page 1 of 3 · 44 trades